Vasoactive Intestinal Peptide ) for 2 Protein-Coupled Receptor ( VPAC Differentiation Induced by the Type 2 G c-Maf and JunB Mediation of Th 2 Dolganov

[1]  Massimo Gadina,et al.  Cytokines and Transcription Factors That Regulate T Helper Cell Differentiation: New Players and New Insights , 2003, Journal of Clinical Immunology.

[2]  K. Arai,et al.  Role of NFATx (NFAT4/NFATc3) in Expression of Immunoregulatory Genes in Murine Peripheral CD4+ T Cells1 , 2003, The Journal of Immunology.

[3]  N. Krug,et al.  Increased messenger RNA expression of c-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. , 2003, Chest.

[4]  E. Goetzl,et al.  Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1 , 2003, The Journal of Immunology.

[5]  P. Angel,et al.  Th2 cell‐specific cytokine expression and allergen‐induced airway inflammation depend on JunB , 2002, The EMBO journal.

[6]  E. Goetzl,et al.  Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide , 2002, Regulatory Peptides.

[7]  Ian A. White,et al.  An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Paul,et al.  In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Delgado,et al.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[10]  S. Said,et al.  New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody. , 2002, Pulmonary pharmacology & therapeutics.

[11]  Kim Bottomly,et al.  The Potency of TCR Signaling Differentially Regulates NFATc/p Activity and Early IL-4 Transcription in Naive CD4+ T Cells1 , 2002, The Journal of Immunology.

[12]  L. Glimcher,et al.  Interferon Regulatory Factor 4 (IRF4) Interacts with NFATc2 to Modulate Interleukin 4 Gene Expression , 2002, The Journal of experimental medicine.

[13]  E. Goetzl,et al.  Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Goetzl,et al.  Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  R. Szubin,et al.  A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects. , 2001, Genome research.

[16]  R. Flavell,et al.  Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. , 2001, Immunity.

[17]  Andreas Radbruch,et al.  An Instructive Component in T Helper Cell Type 2 (Th2) Development Mediated by Gata-3 , 2001, The Journal of experimental medicine.

[18]  M. O'dorisio,et al.  Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells1 , 2001, The Journal of Immunology.

[19]  M. Delgado,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-κB, NF-AT, and Early Growth Factors 2/31 , 2001, The Journal of Immunology.

[20]  M. Delgado,et al.  TH2 Lymphocytes Secrete Functional VIP upon Antigen Stimulation , 2001, Archives of physiology and biochemistry.

[21]  E. Goetzl,et al.  Vasoactive Intestinal Peptide Mediation of Development and Functions of T Lymphocytes , 2000, Annals of the New York Academy of Sciences.

[22]  S. Szabo,et al.  Transcriptional regulation of Th1/Th2 polarization. , 2000, Immunology today.

[23]  M. Delgado,et al.  Inhibition of IFN-γ-Induced Janus Kinase-1-STAT1 Activation in Macrophages by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide , 2000, The Journal of Immunology.

[24]  A. Rao,et al.  Integration of TCR and IL-4 signals through STAT6 and the regulation of IL-4 gene expression. , 2000, Molecular immunology.

[25]  L. Glimcher,et al.  Lineage commitment in the immune system: the T helper lymphocyte grows up. , 2000, Genes & development.

[26]  J. Li,et al.  IL‐4 regulates VIP receptor subtype 2 mRNA (VPAC2) expression in T cells in murine schistosomiasis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. Ganea,et al.  The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells , 2000, Journal of Neuroimmunology.

[28]  M. Sun,et al.  Innate antibody catalysis. , 1999, Molecular immunology.

[29]  L. Glimcher,et al.  The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. , 1999, Immunity.

[30]  A. Rao,et al.  Molecular Regulation of Cytokine Gene Expression During the Immune Response , 1999, Journal of Clinical Immunology.

[31]  C. Turck,et al.  Enhancement by vasoactive intestinal peptide of γ‐interferon production by antigen‐stimulated type 1 helper T cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  R. Flavell,et al.  Regulation of IL‐4 expression by the transcription factor JunB during T helper cell differentiation , 1999, The EMBO journal.

[33]  A. Rao,et al.  Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. , 1998, Blood.

[34]  Richard A Flavell,et al.  The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.

[35]  D. Ganea,et al.  Down‐regulation of Cytokine Expression in Murine Lymphocytes by PACAP and VIP , 1996, Annals of the New York Academy of Sciences.

[36]  Lei Sun,et al.  Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex , 1993, Journal of Neuroimmunology.

[37]  R. Flavell,et al.  Th1 and Th2 cells. , 2001, Current opinion in hematology.

[38]  A Radbruch,et al.  Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. , 2000, Immunity.

[39]  Josep M. Guerrero,et al.  Immunobiology of vasoactive intestinal peptide (VIP) , 2000, Immunology today.

[40]  J. Leiden,et al.  Transcriptional regulation of T lymphocyte development and function. , 1999, Annual review of immunology.